NCT06239571

Brief Summary

The goal is to develop, refine, and test the feasibility and acceptability of a dyadic, resiliency intervention ("Resilient Families;" R-FAM) that aims to reduce emotional distress and improve relationships among parents in the Neonatal Intensive Care Unit (NICU). To achieve this goal, my aims are three-fold: (1) develop R-FAM using stakeholder input from interviews with parent dyads and focus groups with NICU staff; (2) optimize R-FAM through an open pilot with pre/post assessments and exit interviews; and (3) test R-FAM for feasibility and acceptability through a randomized clinical trial of R-FAM compared with a minimally enhanced usual control (MEUC).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
23mo left

Started May 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
May 2025Mar 2028

First Submitted

Initial submission to the registry

January 25, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 2, 2024

Completed
1.3 years until next milestone

Study Start

First participant enrolled

May 8, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2028

Last Updated

January 28, 2026

Status Verified

May 1, 2025

Enrollment Period

1.9 years

First QC Date

January 25, 2024

Last Update Submit

January 26, 2026

Conditions

Keywords

Neonatal Intensive Care UnitParental mental healthParental relationships

Outcome Measures

Primary Outcomes (3)

  • Depression

    Level of depression endorsed on Hospital Anxiety \& Depression Scale and Edinburgh Postnatal Depression Scale, from 0-30 with 30 indicating highest depression

    Baseline to end of intervention (6 weeks)

  • Anxiety

    Level of anxiety endorsed on Hospital Anxiety \& Depression Scale, from 0-21 with 21 indicating highest anxiety

    Baseline to end of intervention (6 weeks)

  • Posttraumatic Stress

    Level of posttraumatic stress endorsed on Impact of Event Scale-6, from 6-24 with 24 indicating highest posttraumatic stress

    Baseline to end of intervention (6 weeks)

Secondary Outcomes (2)

  • Couple relationship functioning

    Baseline to end of intervention (6 weeks)

  • Family Impact

    Baseline to end of intervention (6 weeks)

Study Arms (1)

Dyadic Resiliency Intervention

EXPERIMENTAL

All participants will receive the intervention, a brief dyadic resiliency intervention

Behavioral: Resilient Families (R-FAM)

Interventions

Dyadic, resiliency intervention that aims to reduce depression, anxiety, and posttraumatic stress among parents of babies in the NICU

Dyadic Resiliency Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult parent/legal guardian (and/or their partner) of a baby admitted to the NICU within past week (age ≥ 18)
  • Currently in an intimate relationship and will live with baby after NICU discharge
  • At least one dyad member is emotionally distressed (HADS \>7 on depression or anxiety subscale)
  • English fluency/literacy
  • Ability and willingness to participate via live video

You may not qualify if:

  • Baby is expected to pass away (as determined by medical team)
  • Current, untreated psychosis or substance dependence/abuse
  • Current self-report of suicidal ideation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mass General Brigham

Boston, Massachusetts, 02114, United States

Location

Study Officials

  • Victoria Grunberg

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Psychologist

Study Record Dates

First Submitted

January 25, 2024

First Posted

February 2, 2024

Study Start

May 8, 2025

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

March 31, 2028

Last Updated

January 28, 2026

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations